BeOne Medicines Ltd. Income Statement

Income Statement Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 13.04M8.82M1.07M238.39M198.22M308.87M1176.28M1415.92M2458.78M3810.24M
Cost of Revenue 4.97M28.70M71.19M70.66M164.91M286.48M379.92M594.09M
Gross Profit 13.04M8.82M1.07M233.41M169.51M238.22M1011.38M1129.45M2078.86M3216.15M
Operating items
Amortization - Intangibles 0.25M0.89M1.33M0.85M1.72M3.98M7.24M
Research & Development 21.86M58.25M98.03M269.02M679.00M927.34M1294.88M472.46M1640.51M1778.59M1953.30M
Selling, General & Administrative 6.93M7.31M20.10M62.60M195.38M388.25M600.18M203.97M1278.60M1508.00M1831.06M
Other Operating Expenses 5.22M29.60M72.52M71.50M
Operating Expenses 28.79M65.56M118.13M336.84M903.99M1388.10M1966.56M676.44M2919.11M3286.59M3784.35M
Operating Income -15.76M-56.74M-117.06M-98.46M-705.77M-959.89M-1657.68M-676.44M-1789.66M-1207.74M-568.20M
EBIT -15.76M-56.74M-117.06M-98.46M-705.77M-959.89M-1657.68M-676.44M-1789.66M-1207.74M-568.20M
Non-operating items
Interest & Investment Income 52.48M74.01M47.84M
Other Non Operating Income 2.88M1.22M-0.97M11.50M1.99M7.17M37.49M-773.67M-223.85M307.89M-12.64M
Non Operating Income 1.08M12.69M-0.97M11.50M1.99M7.17M37.49M-773.67M-223.85M307.89M-12.64M
Net income details
EBT -18.55M-57.10M-119.16M-91.06M-689.83M-943.59M-1618.19M-1457.82M-1961.04M-825.84M-533.00M
Tax Provisions 0.05M2.23M-15.80M6.99M10.40M42.78M55.87M111.78M
Profit After Tax -18.55M-57.10M-119.22M-93.30M-674.03M-950.58M-1628.59M-1457.82M-2003.82M-881.71M-644.79M
Equity Income 11.83M7.63M-22.00M-16.22M
Net Income - Minority -14.42M-14.45M-16.15M
Income from Non-Controlling Interests -0.27M-0.19M-0.26M-1.95M-3.62M
Income from Continuing Operations -18.55M-57.10M-119.22M-93.30M-674.03M-950.58M-1628.59M-1457.82M-2003.82M-881.71M-644.79M
Consolidated Net Income -18.55M-57.10M-119.22M-93.30M-674.03M-950.58M-1628.59M-1457.82M-2003.82M-881.71M-644.79M
Income towards Parent Company -18.55M-57.10M-119.22M-107.72M-688.48M-966.73M-1628.59M-1457.82M-2003.82M-881.71M-644.79M
Net Income towards Common Stockholders -18.28M-57.10M-119.22M-93.11M-688.48M-966.73M-1628.59M-1457.82M-2003.82M-881.71M-644.79M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 395.76M427.44M429.49M696.34M776.11M788.34M1182.92M1219.73M1349.64M1359.50M1386.03M
EBITDA -15.76M-56.74M-117.06M-98.46M-705.77M-959.89M-1657.68M-676.44M-1789.66M-1207.74M-568.20M
Tax Rate 2.29%